Oral peptides with dual mu/delta opioid receptor agonist activities are superior to eluxadoline in preclinical models of IBS-DL. Mattheakis, S. -K. Anandan, L. Zhao, N. Zerangue,G. Bourne,S. Shah,A. Stephenson, T. Annamalai,A. Bhandari,D. Y. LiuGastroenterology（2018）引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
